Greenwich LifeSciences, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Mailing Address 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Phone 203-434-3290
Fiscal Year End 1231
EIN 205473709
Financial Overview
FY2024
-$8.89M
Net Income
$6.99M
Cash & Equivalents
$-0.69
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 28, 2025 | View on SEC |
| 4 Insider stock transaction report | November 17, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 4 Insider stock transaction report | November 12, 2025 | View on SEC |
Insider Trading
BUY 1 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.